QTI

QT Imaging Holdings, Inc. Common Stock
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$52.60M
P/E Ratio
EPS
$-1.05
Beta
-0.04
52W High
$46.05
52W Low
$3.63
50-Day MA
$5.04
200-Day MA
$9.75
Dividend Yield
Profit Margin
-58.90%
Forward P/E
PEG Ratio

About QT Imaging Holdings, Inc. Common Stock

QT Imaging Holdings, Inc. engages in the manufacturing, research, and development of automated breast imaging system for producing high-resolution transmission ultrasound images. The company is headquartered in Novato, California.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$22.66M
Gross Profit (TTM)$9.44M
EBITDA$-5.63M
Operating Margin-36.00%
Return on Equity-178.60%
Return on Assets-21.80%
Revenue/Share (TTM)$1.95
Book Value$0.32
Price-to-Book14.68
Price-to-Sales (TTM)2.32
EV/Revenue2.319
EV/EBITDA-6.11
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)133.40%
Shares Outstanding$13.77M
Float$7.48M
% Insiders25.07%
% Institutions17.09%

Historical Volatility

HV 10-Day
46.25%
HV 20-Day
51.96%
HV 30-Day
62.03%
HV 60-Day
78.94%
HV Rank

Volatility is currently contracting

Analyst Ratings

Consensus ($11.60 target)
2
Buy

Latest News

QT Imaging Announces Successful Completion of First FDA Routine Inspection with Zero Form 483 Observations

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in the research, development, and commercialization of innovative body imaging systems, announces the successful completion of its first routine inspection by the U.S. Food and Drug Administration (FDA), with zero Form 483 observations. The FDA inspection reviewed QT Imaging's Quality Management System (QMS) and related processes that support the Company's o.

Business Wire7/7/2026Neutral
A New Standard of Reproducibility for Quantitative Biomarkers in Breast Imaging

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported the characterization of repeatability and reproducibility metrics for quantitative biomarkers generated by its QT Imaging Breast Acoustic CTTM Scanner platform.As healthcare increasingly adopts quantitative imaging biomarkers to monitor disease, as.

Business Wire6/24/2026Neutral
QT Imaging Receives Saudi Arabia FDA Regulatory Clearance

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that its Breast Acoustic CT™ scanner has received official classification and clearance from the Kingdom of Saudi Arabia (KSA) for use as a medical device in that country. The Saudi Food and Drug Authority (SFDA) approval allows QT Imaging's Brea.

Business Wire6/3/2026Neutral
QT Imaging Set to Join the Russell Microcap® Index

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancerAwareness--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announces that it is expected to be added to the Russell Microcap® Index according to the list of additions posted online May 22, 2026. The addition of QT Imaging to this Index will be finalized at the conclusion of the 2026 Russell indexes reconstitution and, i.

Business Wire5/27/2026Neutral
QT Imaging Holdings Announces Closing of $10 Million Underwritten Public Offering

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancerAwareness--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (Nasdaq: QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today the closing of its previously announced underwritten public offering of 2,000,000 shares of common stock (or pre-funded warrants in lieu thereof) for gross proceeds of approximately $10 million. Participants in this offering included current inve.

Business Wire5/18/2026Neutral
QT Imaging Holdings Announces Pricing of $10 Million Underwritten Public Offering

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (Nasdaq: QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today the pricing of an underwritten public offering of 2,000,000 shares of common stock (or pre-funded warrants in lieu thereof) for gross proceeds of $10 million. Ladenburg Thalmann & Co. Inc. is acting as sole book-running manager and Northland.

Business Wire5/15/2026Neutral
QT Imaging Reports First Quarter 2026 Revenue of $6.5 Million

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three months ended March 31, 2026 and provided a business update. “We continued to execute during the first quarter, making meaningful progress across commercialization, regulatory execution, and clinical validation,” sai.

Business Wire5/13/2026Neutral
QT Imaging to Hold First Quarter 2026 Conference Call on May 13, 2026

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the three months ended March 31, 2026 after market close on Wednesday, May 13, 2026 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time. Date/Time:   Wednesd.

Business Wire5/6/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026